Hints and tips:
Related Special Reports
...Cancer Research UK, which received £261mn in gifts from wills last year — its largest source of income — said the time taken to receive such funds had a “detrimental impact” on the charity “and our investment...
...AstraZeneca beat analysts’ estimates with 19 per cent growth in revenue in the first quarter of 2024, driven by stronger sales of its cancer drugs....
...Merck has upped its profit and revenue guidance for this year as sales of its blockbuster cancer treatment Keytruda continue to surge....
...King Charles III is to return to public duties next week after temporarily stepping back from the spotlight during treatment for cancer....
...“Early diagnosis needs to be connected to treatment or it is pointless,” said Nick James, professor at the UK Institute of Cancer Research and leader of the work on prostate cancer....
...The success for Imfinzi, which is approved for other cancers, comes after a setback in a trial in November to expand its use for another terminal lung cancer....
...Catherine, Princess of Wales, is undergoing treatment for cancer, which was discovered after undergoing major abdominal surgery in January....
...Female breast cancer is the most common form of cancer in the UK and accounts for 15 per cent of all new cases, according to the Breast Cancer UK charity....
...King Charles III has been diagnosed with a form of cancer, Buckingham Palace said on Monday....
...Around 1,000 people in England would be eligible for the treatment each year, according to charity Breast Cancer Now....
...cancer”....
...Sales of cancer drugs helped AstraZeneca to beat City expectations in 2023, as the FTSE 100 company forecast continued double-digit sales growth in 2024....
...“It can result in the overdiagnosis of low-risk prostate cancers while also missing some high-risk cancers.”...
...Cancer Research UK estimates that each year, if survival by stage across England matched the best performing areas, about 1,400 more lung cancer patients, and 840 more bowel cancer patients, could survive...
...A widely used screening test for prostate cancer is over-diagnosing insignificant cases while still missing some of the most aggressive cancers, according to the largest study of its kind....
...US defence secretary Lloyd Austin was released from hospital on Monday, more than two weeks after he was admitted over complications from prostate cancer treatment....
...He was diagnosed with prostate cancer in early December and underwent a minimally invasive prostatectomy to treat and cure the cancer on December 22, Maddox and Chestnut said....
...new therapies, new diagnostics and new screening approaches for cancer”....
...However, tests after the operation found cancer had been present.”...
...“Subsequent diagnostic tests have identified a form of cancer,” Buckingham Palace added. The palace did not specify the form of cancer....
...Nice said it did not approve Enhertu for metastatic breast cancer with low levels of HER2, a protein that promotes growth of cancer cells, after chemotherapy....
...In addition, the company said it was progressing towards US approval of an innovative cancer drug Datopotamab deruxtecan for the treatment of patients with advanced lung cancer....
...Illumina, the US maker of machines to sequence the human genome, will divest Grail, the cancer screening start-up it acquired in 2021 for nearly $8bn without the European Commission’s approval....
...Cancer Research UK has warned that NHS cancer services are “in crisis”, with the charity calling on the government to invest further in staff and research into the disease....
International Edition